| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Cytochrome P450 2C9 | 0 | 6 | 1 | 7 |
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 8 | 0 | 0 | 8 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 17 | 0 | 0 | 17 |
| USP1 protein, partial | 23 | 0 | 0 | 23 |
| TDP1 protein | 38 | 0 | 0 | 38 |
| vitamin D3 receptor isoform VDRA | 13 | 0 | 0 | 13 |
| importin subunit beta-1 isoform 1 | 7 | 0 | 0 | 7 |
| flap endonuclease 1 | 7 | 0 | 0 | 7 |
| serine/threonine-protein kinase PLK1 | 7 | 0 | 0 | 7 |
| snurportin-1 | 7 | 0 | 0 | 7 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 9 | 0 | 0 | 9 |
| GTP-binding nuclear protein Ran isoform 1 | 5 | 0 | 0 | 5 |
| DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 9 | 0 | 0 | 9 |
| urokinase-type plasminogen activator precursor | 7 | 0 | 0 | 7 |
| plasminogen precursor | 7 | 0 | 0 | 7 |
| urokinase plasminogen activator surface receptor precursor | 7 | 0 | 0 | 7 |
| geminin | 27 | 0 | 0 | 27 |
| DNA polymerase kappa isoform 1 | 14 | 0 | 0 | 14 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 2 | 2 | 5 |
| Fatty acid-binding protein, intestinal | 0 | 5 | 2 | 7 |
| Fatty acid-binding protein, adipocyte | 0 | 6 | 2 | 8 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
| Fatty acid-binding protein 5 | 0 | 3 | 1 | 4 |
| Fatty acid-binding protein 5 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
| Oxysterols receptor LXR-alpha | 0 | 0 | 1 | 1 |
| Protein skinhead-1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 6 | 0 | 0 | 6 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 1 | 1 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 22 | 0 | 0 | 22 |
| Chain A, Avidin | 0 | 0 | 2 | 2 |
| Chain A, Avidin | 0 | 0 | 2 | 2 |
| Chain B, Avidin | 0 | 0 | 2 | 2 |
| Fumarate hydratase | 7 | 0 | 0 | 7 |
| AR protein | 40 | 0 | 0 | 40 |
| EWS/FLI fusion protein | 21 | 0 | 0 | 21 |
| polyprotein | 7 | 0 | 0 | 7 |
| histone acetyltransferase KAT2A isoform 1 | 12 | 0 | 0 | 12 |
| ATP-binding cassette sub-family C member 3 | 0 | 22 | 0 | 22 |
| Multidrug resistance-associated protein 4 | 0 | 22 | 0 | 23 |
| Bile salt export pump | 0 | 32 | 0 | 32 |
| Cellular tumor antigen p53 | 26 | 0 | 0 | 26 |
| Hydroxycarboxylic acid receptor 2 | 0 | 2 | 2 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 19 | 0 | 19 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 17 | 0 | 0 | 17 |
| Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
| Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
| Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
| Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 24 | 0 | 0 | 24 |
| nuclear receptor subfamily 1, group I, member 3 | 16 | 0 | 0 | 16 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
| glucocorticoid receptor [Homo sapiens] | 27 | 0 | 0 | 27 |
| estrogen-related nuclear receptor alpha | 30 | 0 | 0 | 30 |
| pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
| estrogen nuclear receptor alpha | 45 | 0 | 0 | 45 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 12 |
| heat shock protein beta-1 | 17 | 0 | 0 | 17 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 26 | 0 | 0 | 26 |
| Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 13 | 2 | 1 | 16 |
| Xanthine dehydrogenase/oxidase | 0 | 4 | 0 | 4 |
| TAR DNA-binding protein 43 | 11 | 0 | 0 | 11 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 9 | 0 | 0 | 9 |
| Ataxin-2 | 10 | 0 | 0 | 10 |
| interleukin 8 | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
| estrogen receptor 2 (ER beta) | 16 | 0 | 0 | 16 |
| progesterone receptor | 17 | 0 | 0 | 17 |
| IDH1 | 11 | 0 | 0 | 11 |
| euchromatic histone-lysine N-methyltransferase 2 | 24 | 0 | 0 | 24 |
| Bloom syndrome protein isoform 1 | 11 | 0 | 0 | 11 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 24 | 0 | 0 | 24 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 25 | 0 | 0 | 25 |
| survival motor neuron protein isoform d | 12 | 0 | 0 | 12 |
| Polyphenol oxidase 2 | 0 | 3 | 0 | 3 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 2 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 4 | 1 | 5 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Shiga toxin subunit A | 0 | 2 | 0 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 14 | 0 | 0 | 14 |
| Chain A, Beta-lactamase | 12 | 0 | 0 | 12 |
| Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain A, 2-oxoglutarate Oxygenase | 11 | 0 | 0 | 11 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| Chain A, Cruzipain | 6 | 0 | 0 | 6 |
| Luciferase | 10 | 0 | 0 | 10 |
| 15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
| WRN | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 21 | 0 | 0 | 21 |
| hypoxia-inducible factor 1 alpha subunit | 13 | 0 | 0 | 13 |
| SMAD family member 2 | 13 | 0 | 0 | 13 |
| GLS protein | 8 | 0 | 0 | 8 |
| SMAD family member 3 | 13 | 0 | 0 | 13 |
| GLI family zinc finger 3 | 25 | 0 | 0 | 25 |
| Microtubule-associated protein tau | 19 | 0 | 0 | 19 |
| thioredoxin glutathione reductase | 7 | 0 | 0 | 7 |
| regulator of G-protein signaling 4 | 12 | 0 | 0 | 12 |
| retinoic acid nuclear receptor alpha variant 1 | 26 | 0 | 0 | 26 |
| retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
| farnesoid X nuclear receptor | 14 | 0 | 0 | 14 |
| peroxisome proliferator-activated receptor delta | 22 | 0 | 0 | 22 |
| peroxisome proliferator activated receptor gamma | 24 | 0 | 0 | 24 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 21 | 0 | 0 | 21 |
| activating transcription factor 6 | 14 | 0 | 0 | 14 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 16 | 0 | 0 | 16 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 15 | 0 | 0 | 15 |
| Caspase-7 | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 8 | 0 | 0 | 8 |
| phospholipase A2 precursor | 0 | 1 | 0 | 1 |
| caspase-3 | 5 | 0 | 0 | 5 |
| cysteine protease ATG4B isoform a | 0 | 1 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 15 | 0 | 0 | 15 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 4 | 0 | 0 | 4 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 15 | 0 | 0 | 15 |
| Free fatty acid receptor 1 | 0 | 0 | 3 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 5 | 0 | 0 | 5 |
| Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
| Trypsin | 0 | 5 | 0 | 5 |
| Coagulation factor VII | 0 | 5 | 0 | 5 |
| Aromatase | 0 | 5 | 0 | 5 |
| Tissue factor | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit delta | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 15 | 0 | 0 | 15 |
| Prostaglandin G/H synthase 1 | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 15 | 0 | 0 | 15 |
| Peroxisome proliferator-activated receptor gamma | 0 | 5 | 14 | 20 |
| Histamine H2 receptor | 8 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 15 | 1 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 15 | 0 | 0 | 15 |
| Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 6 |
| Free fatty acid receptor 4 | 0 | 0 | 2 | 2 |
| GABA theta subunit | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit epsilon | 15 | 0 | 0 | 15 |
| ATP-dependent phosphofructokinase | 13 | 0 | 0 | 13 |
| glucocerebrosidase | 7 | 0 | 0 | 7 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 2 | 2 | 4 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
| nuclear receptor ROR-gamma isoform 1 | 13 | 0 | 0 | 13 |
| caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 10 | 1 | 12 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 4 | 4 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Calmodulin | 0 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 3 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 10 | 0 | 12 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 15 | 0 | 19 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| muscarinic acetylcholine receptor M1 | 8 | 0 | 0 | 8 |
| lethal factor (plasmid) | 8 | 0 | 0 | 8 |
| Cytochrome P450 3A4 | 0 | 6 | 1 | 8 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 3 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 10 | 0 | 0 | 10 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 2 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 3 | 5 |
| Spike glycoprotein | 10 | 0 | 1 | 11 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 5 |
| Carbonic anhydrase 2 | 0 | 3 | 0 | 6 |
| Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
| Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
| Amino acid transporter | 0 | 2 | 0 | 2 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 8 | 3 | 11 |
| Integrin beta-3 | 2 | 1 | 1 | 4 |
| Myeloperoxidase | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 3 | 0 | 3 |
| Integrin alpha-IIb | 2 | 1 | 1 | 4 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 5 | 0 | 1 | 6 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 3 | 3 |
| caspase 7, apoptosis-related cysteine protease | 9 | 0 | 0 | 9 |
| caspase-3 | 9 | 0 | 0 | 9 |
| thyroid hormone receptor beta isoform a | 10 | 0 | 0 | 10 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 4 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 7 | 0 | 7 |
| ATP-dependent translocase ABCB1 | 0 | 10 | 2 | 19 |
| Insulin receptor | 0 | 5 | 0 | 5 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 6 | 0 | 6 |
| Histone deacetylase 1 | 0 | 4 | 0 | 4 |
| Histone deacetylase 2 | 0 | 4 | 0 | 4 |
| Histone deacetylase 6 | 0 | 3 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 1 | 5 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| Sterol O-acyltransferase 1 | 0 | 3 | 0 | 3 |
| Sterol O-acyltransferase 2 | 0 | 1 | 0 | 1 |
| Myc proto-oncogene protein | 0 | 1 | 0 | 1 |
| Interferon beta | 20 | 0 | 0 | 20 |
| Sterol O-acyltransferase 1 | 0 | 3 | 0 | 3 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 2 | 0 | 2 |
| core protein, partial | 0 | 1 | 0 | 1 |
| peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
| G | 17 | 0 | 0 | 17 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 3 | 4 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 3 | 9 |
| HLA class I histocompatibility antigen, B alpha chain | 17 | 0 | 0 | 17 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 5 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 5 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 5 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 5 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 5 | 5 |
| Peroxisome proliferator-activated receptor alpha | 0 | 2 | 6 | 8 |
| Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 7 | 8 |
| Peroxisome proliferator-activated receptor delta | 0 | 0 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 3 | 4 |
| Peroxisome proliferator-activated receptor alpha | 4 | 6 | 11 | 21 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 3 | 4 |
| Inositol hexakisphosphate kinase 1 | 17 | 0 | 0 | 17 |
| cytochrome P450 2C9, partial | 17 | 0 | 0 | 17 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 8 | 0 | 0 | 8 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 12 | 0 | 0 | 12 |
| 67.9K protein | 5 | 0 | 0 | 5 |
| thyrotropin-releasing hormone receptor | 5 | 0 | 0 | 5 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 4 | 2 | 6 |
| Vitamin D3 receptor | 0 | 4 | 4 | 8 |
| Alpha-2C adrenergic receptor | 0 | 0 | 2 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
| Ileal sodium/bile acid cotransporter | 0 | 3 | 0 | 3 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | 0 | 1 | 4 | 5 |
| Bile acid receptor | 0 | 1 | 4 | 5 |
| Ubiquitin carboxyl-terminal hydrolase 2 | 0 | 2 | 0 | 2 |
| Phospholipase A2 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 3 | 8 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 3 | 8 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 3 | 8 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 3 | 8 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 3 | 8 |
| G-protein coupled bile acid receptor 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 3 | 8 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 3 | 8 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 5 | 0 | 7 |
| Solute carrier family 22 member 1 | 0 | 6 | 0 | 7 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
| Histamine H2 receptor | 0 | 6 | 0 | 6 |
| Histamine H1 receptor | 0 | 0 | 2 | 2 |
| Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 8 | 0 | 3 | 0 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 3 | 0 | 4 |
| aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 4 | 4 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
| GALC protein | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 9 | 0 | 0 | 9 |
| cytochrome P450 2D6 isoform 1 | 4 | 0 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 0 | 2 | 2 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| pregnane X receptor | 5 | 0 | 0 | 5 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Chain A, STEROID DELTA-ISOMERASE | 0 | 0 | 1 | 1 |
| Steroid Delta-isomerase | 0 | 0 | 1 | 1 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| AAA family ATPase | 0 | 0 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 2 | 3 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostacyclin receptor | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| RGS12 | 1 | 0 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| Smad3 | 7 | 0 | 0 | 7 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| isocitrate dehydrogenase 1, partial | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| LANA | 0 | 0 | 0 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| serine-protein kinase ATM isoform a | 4 | 0 | 0 | 4 |
| lysosomal alpha-glucosidase preproprotein | 5 | 0 | 0 | 5 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 8 | 0 | 0 | 8 |
| muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
| kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 6 | 0 | 0 | 6 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 3 | 0 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 4 | 5 |
| Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
| Vpr | 2 | 0 | 0 | 2 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 7 | 2 | 10 |
| Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
| Adenosine receptor A3 | 0 | 6 | 0 | 6 |
| Androgen receptor | 0 | 7 | 0 | 7 |
| Alpha-1B adrenergic receptor | 0 | 7 | 0 | 7 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 4 |
| Sodium-dependent noradrenaline transporter | 0 | 8 | 1 | 9 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Mu-type opioid receptor | 0 | 4 | 1 | 5 |
| Kappa-type opioid receptor | 0 | 4 | 1 | 5 |
| Alpha-1A adrenergic receptor | 0 | 7 | 0 | 7 |
| Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
| Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
| Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 6 | 2 | 8 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 2 | 1 | 3 |
| Beta-3 adrenergic receptor | 0 | 4 | 0 | 4 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cruzipain | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
| D(3) dopamine receptor | 0 | 6 | 0 | 6 |
| Chloride channel isoform 1 | 0 | 0 | 2 | 2 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 4 | 1 | 0 | 5 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
| Menin | 0 | 0 | 1 | 1 |
| Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 2 | 1 | 3 |
| Cannabinoid receptor 2 | 0 | 0 | 2 | 2 |
| Guanylate cyclase soluble subunit alpha-1 | 0 | 0 | 1 | 1 |
| Guanylate cyclase soluble subunit beta-1 | 0 | 0 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 6 | 0 | 6 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 4 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 1 | 1 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 2 | 1 | 3 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
| Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 5 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 6 | 0 | 6 |
| Proton-coupled amino acid transporter 1 | 0 | 4 | 0 | 5 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Ricin | 0 | 1 | 0 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
| Guanine deaminase | 0 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
| Alpha-crystallin B chain | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 0 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
| Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
| Chain A, Antigen Cd11a (p180) | 0 | 1 | 0 | 1 |
| PINK1 | 3 | 0 | 0 | 3 |
| Parkin | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Integrin beta-2 | 0 | 1 | 0 | 1 |
| Intercellular adhesion molecule 1 | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Integrin alpha-L | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 4 | 0 | 4 |
| Dihydrofolate reductase | 0 | 3 | 0 | 3 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Cholesteryl ester transfer protein | 0 | 2 | 0 | 2 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
| Nicotinamidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
| D-aspartate oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
| Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| putative potassium channel subunit | 0 | 0 | 1 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 3 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 3 | 0 | 3 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 1 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 2 | 0 | 1 | 0 | 1 |
| Renin | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Progesterone receptor | 0 | 3 | 0 | 4 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Vascular cell adhesion protein 1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 2 | 0 | 2 |
| NADH-cytochrome b5 reductase 3 | 0 | 1 | 0 | 1 |
| Thyroid peroxidase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
| Prolyl 4-hydroxylase, beta polypeptide | 0 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Estrogen receptor | 0 | 1 | 1 | 3 |
| Gastric inhibitory polypeptide receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 1 | 3 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 0 | 0 | 1 |
| ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 2 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 2 | 0 | 2 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 2 | 1 | 3 |
| P2Y purinoceptor 2 | 0 | 1 | 2 | 3 |
| Protein kinase C iota type | 0 | 2 | 0 | 2 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 2 | 0 | 1 | 1 | 2 |
| P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 4 | 0 | 0 | 2 | 2 |
| NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 1 | 0 | 1 |
| DNA primase | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 6 | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 2 | 0 | 2 |
| Dual specificity protein phosphatase 5 | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 8 | 0 | 1 | 0 | 1 |
| RmtA | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 3 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 11 | 0 | 1 | 2 | 3 |
| P2X purinoceptor 7 | 0 | 0 | 1 | 1 |
| Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 1 | 3 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| P2Y purinoceptor 4 | 0 | 0 | 1 | 1 |
| N-acetyllactosaminide alpha-1,3-galactosyltransferase | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 2 | 0 | 1 | 1 | 2 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase | 0 | 0 | 0 | 1 |
| M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |